The US Food and Drug Administration provides drug firms with a draft guidance on quality for eye drops and other topical ophthalmic products following a jump the past two years in contamination problems.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?